A 2019 survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient and effective.
Risk-Based Monitoring (RBM) makes an impact.
The 2019 paperreport, Establishing Risk-Based Monitoring within a Quality-Based System as “Best Practice” for Clinical Studies, found that when a company reviews data through a centralized system using the RBM model, CROs and technology companies are better able to detect quality issues earlier and make rapid corrections at the site level.Read and download the full paper below.
Establishing Risk-Based Monitoring within a Quality-Based System as “Best Practice” for Clinical Studies
See conceptual framework below.